Z.I.A.D. Healthcare for the Underserved Inc. is a 501c3 Non Profit organization that came to be in 2002 when four individuals sat down and looked for ways to help provide access to the uninsured. Specifically they looked at those that fall through cracks, some 46,000,000 people in the United States. These are the people that work part time jobs (making them unqualified for governmental assistance), and receive no coverage from their employers, and cannot afford the premiums of health insurance.
Z.I.A.D. derives its name from the names of its founders Ray Zak, Iqbal Nasser MD, Ibraham Ahmed ND, Theodore Densley MD. Z.I.A.D. primarily works with private doctors to find a primary care home for the uninsured on a sliding scale program where they receive reduced office costs based on federal poverty guidelines.
If you are a primary care office and would like to participate in the program please call 313-815-8767.
A practical guide to understanding meta-analysis, pooled estimates, heterogeneity, study quality, publication bias, and certainty of evidence.
Learn how a prospective U.S. prescription drug moves from laboratory research through clinical trials, FDA review, approval, and continuing safety monitoring.
Resting metabolic rate reflects the energy your body uses while at rest. Learn what affects RMR, how it differs from BMR, and how to interpret a test or estimate.
A 50% lower risk can represent a large benefit or a tiny difference. Learn how relative risk, absolute risk, baseline risk, and NNT work together.
There is no universal plain-water quota. Learn how to use total-water benchmarks, thirst, activity, climate, diet, and health factors to guide hydration.
An adverse event happened after treatment, but that timing alone does not prove causation. Learn what safety terms mean and how to read trial tables responsibly.
On August 9, 2022 Ray Zak the president of the board of ZIAD received a prestigious award from the Wayne County Health Authority for the work done by him in leadership of ZIAD Healthcare for the Underserved.
The plaque was awarded and titled “The Best Safety Net Award” with the following inscription:
“On The ninth day of August , 2022, in recognition for extraordinary commitment and service to community health care, we recognize Ray Zak.” The plaque was signed by Gail Warden and Chris Allen of the Wayne County Health Authority. Congratulations to Ray Zak on his devoted leadership of Z.I.A.D.
ZIAD Health Care for the Underserved participated in a health and community fair at Resurrection Lutheran Church Kelly Rd., Detroit, MI.. ZIAD provided the community with information on services that are available for the uninsured, and also provided Free Blood Pressure screening.The event was a cooperative program of three Lutheran churches in the Detroit area. Many residents turned out for the free information, screening, community togetherness, and some free hot dogs. Click here to see pictures from the event.
As always for information on health care call ZIAD at 313-815-8767
A Letter from the HeartDear Friends of ZIAD,
I have been blessed my entire life with the luxury of health insurance. My Father provided for me when I was a child, and I have been fortunate enough in my adult life to provide coverage for myself and my family. Recently, however, my son was stricken with a very rare blood disorder, and we were forced to live in a children’s hospital in Los Angeles for many weeks. I was able to see, first hand, how such a tragedy can financially ruin a family.
The bill for merely the first two weeks in the hospital came to just over $99,000 dollars. One bag of transfusable blood alone cost over $700 dollars. Our son faces a minimum of another 12 to 18 months of treatment. Without insurance, we would have been forced to declare bankruptcy, at the very least. There are thousands of families seeking care for loved ones with life-threatening and chronic afflictions every day. Sadly, the truth is there are many, many families that are turned away from facilities in this great country, only because they do not have enough medical insurance. Please help the gracious people of ZIAD provide care for the underinsured. If you have ever had a loved one need medical attention, you know the urgency of their mission.
Thank you, and may God bless your family with perfect health,
Paul Ganus
Nearly 46 million Americans, including more than 8 million children, are living without health insurance – forced to gamble every day that they won’t get sick or injured. That’s a risk no one should have to take. Uninsured Americans live sick and die younger than those with health insurance. Just one serious illness or injury can wipe out an uninsured family’s bank account, and the problem is getting worse.
To provide health care, health education, physical fitness and other programs to uninsured, under insured, poor, working poor families, and individuals. To provide access to health care in underserved areas, and to the frail elderly.
1) Expand the network of Private doctors offices, and services working with Z.I.A.D. Healthcare for the Underserved that provide primary healthcare as well as other services to underserved, poor, and working poor, and on a sliding scale basis to other geographical areas.
2) Expand services and assistance to the frail elderly.
3) To participate and collaborate with other organizations helping the uninsured or underinsured.
3) To participate and collaborate with Specialty, Pharmacy, Hospital, Dental and other programs to help the uninsured.
4) To identify, apply for and obtain grants that provide screening and outreach to identify disease early up.
Affiliates:
Donations: ZIAD Health Care for the Underserved Inc. is open to all donations public and private and has received Tax Exempt Status with the IRS (#75-3080830).
Donations can be made to ZIAD Health Care via PayPal. Below are buttons that you can use to donate now. We appreciate your donations very much.
If you want meta analysis explained simply, it is a statistical method for combining results from separate studies. Pooling can produce a more precise estimate and reveal patterns that are difficult to see in one small study. It does not automatically make the answer reliable. The result still depends on whether the studies asked comparable questions, measured meaningful outcomes, managed bias, and represented the people or settings relevant to your decision. Treat “meta-analysis” as a description of a method, not a stamp of certainty.
The practical reading strategy is straightforward: look beyond the pooled number. Check the size and uncertainty of the effect, why the studies differed, whether weak studies dominated the evidence, whether results may be missing, and whether the measured benefit matters in real life.
Imagine several studies addressing a similar health question. One reports a benefit, another finds little difference, and a third is too small to provide a clear answer. A meta-analysis expresses the compatible results using a common statistical framework and calculates a pooled estimate. Studies with more precise estimates commonly receive greater weight, although that weight should not be confused with a judgment that the study is necessarily better designed. The Cochrane Handbook’s meta-analysis guidance explains the principles and cautions involved in this process.
The pooled estimate is a summary, not a replacement for the individual studies. It may show an average difference, association, or relative effect, depending on the question and data. An uncertainty interval around that estimate indicates the range of values reasonably compatible with the analysis. A narrow interval is more precise than a wide one, but precision alone cannot correct biased methods or an irrelevant outcome.
A useful analogy is combining several measurements. Repeated measurements can improve confidence when they are valid measures of the same thing. Combining a bathroom scale, a thermometer, and a stopwatch would not produce a better estimate of body weight. In the same way, studies should not be pooled merely because their titles sound related.
A systematic review is the broader research process. Reviewers define a focused question, establish eligibility rules, search for relevant evidence, select studies, extract results, and evaluate limitations. A meta-analysis is an optional quantitative step within that process. Reviewers may reasonably decide not to pool results when studies are too different or the available data are unsuitable.
| Term | What it does | What it does not guarantee |
|---|---|---|
| Systematic review | Uses structured methods to identify, select, appraise, and summarize evidence for a defined question | That all included evidence is trustworthy or that the conclusion is correct |
| Meta-analysis | Statistically combines compatible study results into a pooled estimate | That the included studies are comparable, unbiased, or clinically relevant |
| Evidence certainty assessment | Judges confidence in an estimate using factors such as bias, consistency, precision, and relevance | A simple permanent label that applies to every population and decision |
This distinction matters when reading headlines. A paper can call itself a systematic review without performing a meta-analysis. It can also report a technically sophisticated meta-analysis based on an incomplete search or poorly designed studies. Neither label tells you everything about reliability.
PRISMA 2020 provides reporting guidance intended to make systematic reviews more transparent. Following a reporting checklist can help readers see what researchers did, but transparent reporting does not by itself prove that the methods or conclusions were sound. The PRISMA 2020 statement describes the reporting framework.
Individual studies are often too small to distinguish a modest effect from random variation. Combining compatible results can improve precision, summarize the direction and size of the evidence, and help researchers examine whether findings vary across populations or study designs.
Meta-analysis can also make disagreement visible. Instead of choosing the most dramatic study, readers can see the overall pattern and the uncertainty around it. That is especially useful when several studies appear contradictory because each estimate is imprecise.
But more data are not automatically better evidence. If several studies share the same design flaw, pooling them may produce a very precise estimate of the wrong answer. If the available studies measure short-term laboratory changes rather than outcomes people care about, the pooled result can be mathematically valid yet limited for a health decision.
Heterogeneity means the study results or study characteristics differ. Some variation is expected. The important question is whether the differences are small enough for a pooled summary to remain meaningful.
Clinical differences can include the participants’ ages, baseline health, treatment doses, comparison groups, settings, follow-up periods, and outcome definitions. Methodological differences can include study design, missing-data handling, measurement quality, and risk of bias. Statistical heterogeneity refers to variation in the numerical effects beyond what sampling uncertainty alone would readily explain.
Suppose several exercise studies are pooled. A supervised program for adults with a diagnosed condition, a self-directed program for healthy students, and a brief workplace intervention may all concern exercise, but they do not necessarily estimate one interchangeable effect. The pooled average could conceal which approach worked, for whom, and under what conditions.
I² is a commonly reported statistical summary related to inconsistency among study estimates. It can alert readers to variation, but it does not explain the source or practical importance of that variation. Cochrane cautions against relying on simple I² cutoffs as a stand-alone interpretation. The number should be considered alongside the effect estimates, their direction, the amount of evidence, and the clinical and methodological differences among studies.
Fixed-effect and random-effects models make different assumptions about the effects being summarized. A random-effects analysis allows for variation in underlying effects, but selecting it does not make fundamentally incompatible studies comparable. Researchers still need to investigate why results differ and decide whether an average effect answers a useful question.
Risk of bias concerns systematic features of a study that can push a result away from the truth. Randomization problems, deviations from the intended intervention, missing outcome data, questionable measurement, and selective reporting can all affect an estimate. For randomized trials, the RoB 2 framework evaluates risk of bias for a specific result through structured domains and produces judgments of low risk, some concerns, or high risk.
This result-specific focus is important. A study is not simply “good” or “bad” for every purpose. One outcome may be measured carefully while another relies on incomplete or selectively reported data. A meta-analysis should show how these concerns affect confidence rather than merely listing the studies it included.
GRADE provides another layer of interpretation by considering risk of bias, inconsistency, imprecision, indirectness, and publication bias when assessing certainty in an effect estimate. These domains answer different questions: Are the studies trustworthy? Do they agree? Is the estimate precise? Does the evidence directly match the question? Could missing results distort the record?
A critical-appraisal tool can help readers evaluate the review itself. AMSTAR 2, for example, is designed for systematic reviews of randomized and non-randomized healthcare intervention studies. Its developers caution against reducing the appraisal to a single overall numeric score, because different methodological weaknesses do not have interchangeable consequences.
A meta-analysis can combine only the evidence its authors locate and obtain. Studies with disappointing or inconclusive findings may remain unpublished, while selected outcomes or analyses may be omitted from published reports. If availability is related to the results, the visible literature can present an unrepresentative picture.
Funnel plots and statistical tests may help reviewers investigate possible missing-evidence problems, but asymmetry is a clue rather than a verdict. Differences in study size, methods, populations, or true effects can also create an uneven pattern. Reviewers should examine plausible explanations instead of treating one plot as proof of publication bias.
Start with the direction and size of the estimate. Then inspect its uncertainty. Ask whether the plausible range includes effects that would lead to meaningfully different decisions. A result can meet a conventional threshold for statistical significance while representing a change too small to matter to most patients.
Next, translate relative effects into absolute terms whenever possible. A large relative change can correspond to a small absolute difference when the starting risk is low. Our guide to relative risk versus absolute risk explains why baseline risk changes the practical meaning of an effect.
Outcome choice matters as well. A change in a biomarker is not automatically equivalent to fewer symptoms, better function, improved quality of life, or a lower risk of serious events. Also check follow-up length, harms, treatment burden, and whether the study participants resemble the population to whom the conclusion is being applied.
Context is particularly important for broad claims about supplements or preventive products. A pooled average may conceal differences by nutrient status, dose, formulation, adherence, or baseline risk. The same interpretive issues appear in discussions such as what multivitamin evidence can and cannot show, where the outcome and population matter as much as the study label.
You do not need advanced statistical training to use this checklist. A trustworthy review should explain these issues clearly enough for a careful reader to understand why the authors reached their conclusion.
No. It estimates an effect from the available studies. Confidence depends on the search, included designs, risk of bias, consistency, precision, directness, and completeness of the evidence. A strong meta-analysis can support a conclusion, but the label alone is not proof.
Not necessarily. A well-conducted large trial may be more informative than a pooled set of small, biased, or incompatible studies. Conversely, a careful synthesis of several relevant studies may provide broader and more precise evidence than any one trial. The methods and match to the question determine usefulness.
No. I² should not be used as a stand-alone pass-or-fail threshold. Readers need to examine why studies differ, whether their effects point in similar directions, and whether an average still has a meaningful interpretation.
A forest plot displays the estimates and uncertainty from individual studies, often alongside a pooled result. Use it to compare effect direction, size, precision, and variation rather than looking only at the summary estimate. Plot conventions can vary, so read the labels and legend.
Check who participated, what was actually tested, the comparison used, outcome relevance, follow-up duration, absolute effects, harms, adherence, risk of bias, and certainty. Also ask whether the pooled studies are sufficiently similar to answer the decision you face. Discuss treatment decisions with an appropriate healthcare professional rather than relying on a headline or pooled number alone.
A well-conducted meta-analysis can provide a clearer, more precise view of a body of research. Its value comes from disciplined study selection, sensible pooling, transparent analysis, careful bias assessment, and an honest account of uncertainty—not from combining the largest possible number of papers.
When you encounter a health claim based on a meta-analysis, pause before accepting the headline. Identify the question, inspect the studies and their differences, look at uncertainty and certainty, and translate the result into practical terms. The best pooled estimate is useful only when it summarizes evidence that belongs together and answers a question that matters.